Welcome to our dedicated page for Varex Imaging news (Ticker: VREX), a resource for investors and traders seeking the latest updates and insights on Varex Imaging stock.
Varex Imaging Corporation (NASDAQ: VREX) is a designer and manufacturer of X-ray imaging components and systems used in medical, industrial, and security applications. The VREX news page on Stock Titan aggregates company announcements, earnings releases, conference presentations, and product-related updates so readers can follow how the business is evolving over time.
Recent news for Varex has focused on quarterly and annual financial results, including detailed segment reporting for its Medical and Industrial businesses, as well as reconciliations between GAAP and non-GAAP financial measures. Earnings releases typically discuss revenue trends in medical X-ray components, demand in industrial imaging, and developments affecting specific markets such as China. Management commentary often highlights factors such as segment performance, margins, cash flow from operations, and capital structure items like convertible notes and senior secured notes.
In addition to financial results, Varex issues news about orders and deployments of its high-energy non-intrusive cargo and vehicle inspection systems. These announcements describe international customers placing systems at strategic sea and land ports and reference the company’s reputation in high-energy Linear Accelerator based imaging. The news flow also includes updates on investor conference appearances, where management presents at events hosted by firms such as CJS Securities, Sidoti, and Jefferies.
Visitors to the VREX news page can use this stream of press releases and updates to monitor trends in medical imaging components, industrial and security imaging systems, cargo inspection orders, and corporate developments. Bookmarking the page allows investors and observers to review new announcements alongside prior releases for context on Varex Imaging Corporation’s ongoing disclosures.
Varex Imaging (Nasdaq: VREX) closed a new secured $490 million Credit Facility dated March 13, 2026, maturing March 13, 2031, composed of a $350M term loan, $100M revolver and $40M delayed draw term loan.
The company redeemed $368M of 7.875% senior secured notes using about $42M cash and entered an interest rate swap fixing SOFR at 3.65%, expected to cut annualized cash interest expense by more than $7M.
Varex (Nasdaq: VREX) management will present at two upcoming investor conferences in March 2026: Oppenheimer’s 36th Annual Healthcare, MedTech & Services Virtual Conference and the Sidoti Small Cap Virtual Conference. Webcasts are available via the listed conference links or on Varex's investor website.
Varex Imaging (Nasdaq: VREX) issued a conditional full redemption notice for all outstanding 7.875% senior secured notes due Oct 15, 2027, with a Redemption Date of March 16, 2026 subject to a new credit facility closing.
The outstanding principal is $368,000,000. The redemption price equals 101.969% plus accrued interest, totaling $1,052.72125 per $1,000 principal. The Company intends to fund the payment with proceeds of the New Financing and cash on hand; the redemption is conditional on the Financing Condition.
Varex (Nasdaq: VREX) reported Q1 FY2026 revenue of $210 million, up 5% year-over-year, with Medical at $145 million and Industrial at $65 million. GAAP net income was $0.05 per diluted share; non-GAAP EPS was $0.19. Cash outflow from operations was $16 million; cash and marketable securities totaled $126 million. Q2 guidance: revenue $210–225 million and non-GAAP EPS $0.15–0.25.
Varex Imaging (Nasdaq: VREX) will report unaudited results for Q1 fiscal 2026 after market close on Tuesday, February 10, 2026. A conference call will follow at 3:00 pm Mountain Time the same day and will be webcast live at the company’s investor site.
Investors can join by phone at 877-524-8416 (U.S.) or 412-902-1028 (non-U.S.). A replay will be available from February 10–24, 2026 with access code 13758188. Varex is headquartered in Salt Lake City and employs ~2,400 people worldwide; it designs and manufactures X-ray imaging components and systems for medical, industrial and security uses.
Varex (Nasdaq: VREX) said company management will present at the CJS Securities 26th Annual New Ideas for the New Year Virtual Conference on Wednesday, January 14, 2026 at 3:50pm ET. The presentation will be available via webcast and can be accessed on Varex’s investor website at www.vareximaging.com/news.
Varex (Nasdaq: VREX) reported Q4 FY2025 and full-year results on November 18, 2025. Q4 revenue was $229M (+11% YoY); Medical $152M (+5% YoY) and Industrial $77M (+25% YoY). Q4 non-GAAP gross margin was 34% and non-GAAP EPS was $0.37 (vs $0.19 a year ago). FY2025 revenue was $845M (+4% YoY); non-GAAP EBITDA rose 37% to $122M and non-GAAP EPS was $0.90 (+73%). Cash and equivalents were $155M at year-end after paying principal on convertible notes on June 2, 2025. Q1 FY2026 guidance: revenue $200–$215M, non-GAAP EPS $0.05–$0.25. Conference call held Nov 18, 2025.
Varex Imaging (Nasdaq: VREX) will report unaudited financial results for the fourth quarter and fiscal year 2025 after market close on Tuesday, November 18, 2025. A conference call and live webcast will follow at 3:00 PM Mountain Time that day.
Investors can join the live webcast at www.vareximaging.com/investor-relations/ or by phone at 877-524-8416 (U.S.) and 412-902-1028 (non-U.S.). The call webcast will be archived and a replay will be available from November 18 through December 2, 2025 at 877-660-6853 (U.S.) or 201-612-7415 (non-U.S.) using access code 13756256.
Varex designs and manufactures X-ray imaging components and systems and is headquartered in Salt Lake City, employing about 2,300 people globally.
Varex Imaging Corporation (Nasdaq: VREX) announced its upcoming participation in the Sidoti Small Cap Virtual Conference. The company's management team will deliver a presentation on Wednesday, September 17, 2025 at 3:15 PM ET. Investors can access the webcast through the provided link or via Varex's corporate website at vareximaging.com/news.
Varex Imaging (NASDAQ: VREX) reported Q3 FY2025 financial results with revenues of $203 million, exceeding guidance but down 3% year-over-year. The company's Medical segment revenue decreased 4% to $142 million, while the Industrial segment revenue grew 1% to $61 million.
Non-GAAP gross margin improved to 34% from 32% in Q3 FY2024, with non-GAAP EPS increasing to $0.18 from $0.14. Operating cash flow was $8 million, with cash and equivalents at $153 million after paying down Convertible Notes. For Q4 FY2025, Varex expects revenues between $210-230 million and non-GAAP EPS of $0.10-0.30.